Application of Apoptosis to Cancer Treatment
Springer-Verlag New York Inc.
978-1-4020-3303-2 (ISBN)
Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world’s leading experts in these fields.
Disfunction of the Apoptotic Pathway in Cancer Cells.- Calcium Signaling and Apoptosis Resistance of Cancer Cells.- Cell Clearance and Cancer.- Specific, Pro-Poptotic Cell-Signaling: Design of Novel, Recombinant Targeted Antitumor Agents Operating Exclusively Through Modulation of Cellular Apoptotic Events.- Targeting Oncogenes Which Regulate Apoptosis.- Targeting Cyclins to Cause Cancer Cell Apoptosis.- Apoptosis Induction By Tumor- Targeted Toxins.- Targeting Cell-Death Pathways in Multiple Myeloma: Therapeutic Implications.- Cephalostatin 1-Induced Apoptosis in Tumor Cells.- Hamlet; A Novel Tool to Identify Apoptotic Pathways in Tumor Cells.- Cancer Immunotherapy: On the Trail of a Cure?.- Histone Deacetylase Inhibitors as a Treatment of Trail-Resistant Cancers.- Basis of Cell Kill Following Clinical Radiotherapy.- Imaging of Apoptotic Cells in vivo.- Apoptosis-Inducing Anticancer Drugs in Clinical Trials.
Erscheint lt. Verlag | 14.4.2005 |
---|---|
Zusatzinfo | VIII, 370 p. |
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 156 x 232 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Studium | |
Naturwissenschaften ► Biologie | |
ISBN-10 | 1-4020-3303-6 / 1402033036 |
ISBN-13 | 978-1-4020-3303-2 / 9781402033032 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich